Posts tagged TKAI


Stock Update (NASDAQ:TKAI): Tokai Pharmaceuticals Inc and Otic Pharma Enter into Share Purchase Agreement

Tokai Pharmaceuticals Inc (NASDAQ:TKAI) and Otic Pharma Ltd. announced that the two companies, together with …

Stock Update (NASDAQ:TKAI): Tokai Pharmaceuticals Inc Announces Review of Strategic Alternatives

Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate …

William Blair Analyst Remains Sidelined on Tokai Pharmaceuticals, Inc. (TKAI) Following Q2 Update

William Blair analyst Y. Katherine Xu remains on the sidelines with shares of Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), after …

Company Update (NASDAQ:TKAI): Tokai Pharmaceuticals Inc Reports First Quarter 2016 Financial Results

Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for …

Stock Update (NASDAQ:TKAI): Tokai Pharmaceuticals Inc Announces Oral Presentation on Galeterone at the 2016 AUA Annual Meeting

Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate …

Stock Update (NASDAQ:TKAI): Tokai Pharmaceuticals Inc Names Kelly Lindert, M.D. its Executive Vice President and Head of Development

Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate …

Stock Update (NASDAQ:TKAI): Tokai Pharmaceuticals Inc Reports Full Year 2015 Financial Results

Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate …

Stock Update (NASDAQ:TKAI): Tokai Pharmaceuticals Inc Announces Update on ARMOR3-SV and Expanded Galeterone Clinical Development Program

Tokai Pharmaceuticals Inc (NASDAQ:TKAI) provided an update on its clinical development program evaluating galeterone in the …

Stock Update (NASDAQ:TKAI): Tokai Pharmaceuticals Inc Reports Third Quarter 2015 Financial Results

Tokai Pharmaceuticals Inc (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate …